91 related articles for article (PubMed ID: 8015765)
1. Molecular biology and genetics of epithelial ovarian cancer.
Baker VV
Obstet Gynecol Clin North Am; 1994 Mar; 21(1):25-40. PubMed ID: 8015765
[TBL] [Abstract][Full Text] [Related]
2. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.
Pharoah PD; Easton DF; Stockton DL; Gayther S; Ponder BA
Cancer Res; 1999 Feb; 59(4):868-71. PubMed ID: 10029077
[TBL] [Abstract][Full Text] [Related]
3. The biology of ovarian cancer.
Auersperg N; Edelson MI; Mok SC; Johnson SW; Hamilton TC
Semin Oncol; 1998 Jun; 25(3):281-304. PubMed ID: 9633841
[TBL] [Abstract][Full Text] [Related]
4. BRCA-1 in sporadic epithelial ovarian cancer: lessons learned from the genetics of hereditary disease.
Cannistra SA
Clin Cancer Res; 2007 Dec; 13(24):7225-7. PubMed ID: 18094398
[No Abstract] [Full Text] [Related]
5. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.
Sellar GC; Watt KP; Rabiasz GJ; Stronach EA; Li L; Miller EP; Massie CE; Miller J; Contreras-Moreira B; Scott D; Brown I; Williams AR; Bates PA; Smyth JF; Gabra H
Nat Genet; 2003 Jul; 34(3):337-43. PubMed ID: 12819783
[TBL] [Abstract][Full Text] [Related]
6. Familial ovarian cancer.
Ngan HY; Shepherd JH
Br J Hosp Med; 1994 Jul 13-Aug 16; 52(2-3):99-102. PubMed ID: 7952791
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes in gynecologic malignancy.
Baker V
Curr Opin Obstet Gynecol; 1992 Feb; 4(1):75-80. PubMed ID: 1543833
[TBL] [Abstract][Full Text] [Related]
8. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
Ramus SJ; Pharoah PD; Harrington P; Pye C; Werness B; Bobrow L; Ayhan A; Wells D; Fishman A; Gore M; DiCioccio RA; Piver MS; Whittemore AS; Ponder BA; Gayther SA
Cancer Res; 2003 Jan; 63(2):417-23. PubMed ID: 12543797
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and prognostic significance in ovarian cancer.
Tammela J; Odunsi K
Minerva Ginecol; 2004 Dec; 56(6):495-502. PubMed ID: 15729202
[TBL] [Abstract][Full Text] [Related]
10. RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women.
Kelemen L; Spurdle AB; Purdie DM; Gertig D; Chenevix-Trench G
Cancer Lett; 2005 Feb; 218(2):191-7. PubMed ID: 15670896
[TBL] [Abstract][Full Text] [Related]
11. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
12. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations related to lymph node metastasis and peritoneal dissemination in epithelial ovarian cancers.
Umayahara K; Numa F; Inokuma A; Sueoka K; Kawasaki K; Hirakawa H; Emoto T; Sakaguchi Y; Nawata S; Ogata H; Sakamoto M; Hasumi K; Kawauchi S; Sasaki K; Kato H
Oncol Rep; 2002; 9(5):1115-9. PubMed ID: 12168082
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Havrilesky L; Darcy kM; Hamdan H; Priore RL; Leon J; Bell J; Berchuck A;
J Clin Oncol; 2003 Oct; 21(20):3814-25. PubMed ID: 14551300
[TBL] [Abstract][Full Text] [Related]
15. The biology of ovarian cancer of epithelial origin.
Rabinerson D; Kaplan B; Levavi H; Neri A
Isr J Med Sci; 1996 Nov; 32(11):1128-33. PubMed ID: 8960089
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
Laframboise S; Chapman W; McLaughlin J; Andrulis IL
Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
[TBL] [Abstract][Full Text] [Related]
17. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
[TBL] [Abstract][Full Text] [Related]
18. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
Li AJ; Baldwin RL; Karlan BY
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
[TBL] [Abstract][Full Text] [Related]
19. Biomarker discovery in epithelial ovarian cancer by genomic approaches.
Mok SC; Elias KM; Wong KK; Ho K; Bonome T; Birrer MJ
Adv Cancer Res; 2007; 96():1-22. PubMed ID: 17161674
[TBL] [Abstract][Full Text] [Related]
20. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
Piek JM; Verheijen RH; van Diest PJ
Histopathology; 2009 Mar; 54(4):494-5. PubMed ID: 19309405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
